Rankings
▼
Calendar
LNTH Q3 2018 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena
LNTH
Lantheus Holdings, Inc.
$5B
Q3 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$89M
+11.2% YoY
Gross Profit
$45M
50.5% margin
Operating Income
$16M
18.5% margin
Net Income
$9M
10.4% margin
EPS (Diluted)
$0.24
QoQ Revenue Growth
+3.9%
Cash Flow
Operating Cash Flow
$24M
Free Cash Flow
$19M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$425M
Total Liabilities
$369M
Stockholders' Equity
$56M
Cash & Equivalents
$105M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$89M
$80M
+11.2%
Gross Profit
$45M
$39M
+16.5%
Operating Income
$16M
$13M
+28.5%
Net Income
$9M
$9M
+8.7%
Revenue Segments
Product Revenue, Net
$88M
99%
License and Royalty Revenues
$576,000
1%
← FY 2018
All Quarters
Q4 2018 →